Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Boston Scientific Thinks Big In Heart Failure Risk-Share Plan

This article was originally published in The Gray Sheet

Executive Summary

Value-based care and leveraging digital health and analytics are now viewed as the all-important ingredients in sustainable health care delivery. With that in mind, Boston Scientific and global professional services company Accenture recently joined forces in a total-cost-of-care heart failure project that is rewarded on patient outcomes.

You may also be interested in...



Start Date Set For Bundling, Gainsharing Program For Hip, Knee Implants

CMS gave hospitals and other providers more time to prepare for an expanding bundled payment program targeting hip and knee implant procedures, moving a proposed Jan. 1 start date to April.

Medtronic Adds Telehealth Services With Cardiocom Acquisition

Medtronic hopes the $200 million purchase of telehealth firm Cardiocom will enhance its ability to respond to increasing demands on hospitals to better manage patient outcomes and costs. It will also greatly expand its customer base.

CMS Tinkers With Readmissions Policy, Other Quality Initiatives

The agency plans to be more selective about which hospital readmissions count toward a potential payment reduction in fiscal year 2014, according to its inpatient payment proposal. CMS also proposes hip and knee replacements as a new category of hospital admission to be included in the readmissions reduction program.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT034971

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel